Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-018812

President sold 25,000 shares at $90.00 ($2,250,000)

  • President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-07-07 Option exercise +5,586 $1.81 $10,111 653,593 D
Novak Rodger President 2020-07-07 Option exercise +19,414 $14.00 $271,796 673,007 D
Novak Rodger President 2020-07-07 Sale −25,000 $90.00 $2,250,000 648,007 D
Derivatives
Novak Rodger President 2020-07-07 Option exercise · Stock Option (Right to Buy) −5,586 0 D
Novak Rodger President 2020-07-07 Option exercise · Stock Option (Right to Buy) −19,414 140,826 D
Open-market sales · 25,000 sh · avg $90.00 · $2,250,000
Loading xslF345X03/doc4.xml…